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Intraperitoneal cytostatics impair healing of experimental intestinal
anastomoses
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Summary We investigated the effect of two doses of cytostatics, administered intraperitoneally during 5
consecutive days, on the healing of ileal and colonic anastomoses constructed on the third day. The cytostatics
regimen consisted of a combination of 5-fluorouracil, bleomycin and cisplatin at 10, 2 and 0.35 mg kg-'d',
respectively, or at twice higher doses. The lower dose was similar to that given intravenously in previous
experiments. Rats were sacrificed 3 or 7 days after operation. No effects of cytostatics were observed after 3
days, neither on anastomotic bursting pressure nor on hydroxyproline concentration (jLg/mg dry weight) or
content (ug cm-'). Profound effects were seen at 7 days. In the high dose group, bursting pressures in both
anastomoses were greatly reduced with respect to the control group. Concurrently, collagen synthesis was
severely impaired, as indicated by sustained decreased hydroxyproline concentrations and content. The lower
dose of cytostatics showed essentially similar effects on hydroxyproline parameters, but affected anastomotic
strength less dramatically. The data indicate that, while intraperitoneal chemotherapy may show less detrimen-
tal systemic toxicity and thus allow higher doses, its application as an adjunct to gastrointestinal surgery may
be limited because of its severe effects on anastomotic repair.
The volume of initially inoperable gastrointestinal tumours
can sometimes be reduced by preoperative antineoplastic
chemotherapy in an attempt to render them operable. Post-
operative chemotherapy may kill peroperatively spilled tu-
mour cells. Both interests may be served by application of
peri-operative chemotherapy. Systemically administered che-
motherapeutic agents do not selectively act on malignant
cells: they also affect wound healing (Falcone & Nappi,
1984). In previous studies we have shown that systemic
administration of a combination of 5-fluorouracil, bleomycin
and cisplatin (de Roy van Zuidewijn et al., 1986) or cisplatin
alone (de Roy van Zuidewijn et al., 1988) impairs anas-
tomotic healing in the intestine. Next to disturbance of
wound healing, the therapeutic concentrations of cytostatics
needed in the target area may also induce serious side effects
which make it necessary to break off treatment or to reduce
dosage schedules.
The efficacy of antineoplastic drugs could be enhanced by
applying them locally. Metastatic or recurrent tumour in
most gastrointestinal malignancies generally include the local
suture line and the intraperitoneal surfaces in addition to the
liver. In these cases better cytostatic activity might be achie-
ved with intraperitoneal administration than with systemic
application in the same doses (Dedrick et al., 1978, Cunliffe
& Sugarbaker, 1989). By changing the route of administra-
tion, higher local drug levels can be reached while systemic
concentrations remain below the toxic level. It is unknown if
these high local concentrations, which are presumed to occur
after intraperitoneal injection of cytostatics, will affect intes-
tinal wound healing to the same extent as intravenous
administration according to a similar dosage schedule. There-
fore we have investigated the effects of a 5-day course of
intraperitoneal administration of 5-fluorouracil, bleomycin
and cisplatin on the first healing stage of intestinal anas-
tomoses in the rat.
Materials and methods
Animals
Sixty male Wistar rats (weight 170-230 grams) received
water and food (standard Rat Chow, Hope Farms, Woerden,
the Netherlands) ad libitum. Three groups were formed, each
consisting of 20 animals: a control group, which received
intraperitoneal saline, and two groups which received intra-
peritoneal cytostatics at two different dosages (cyto 1 and
cyto 2, respectively). Within each group, ten rats were meant
to be sacrificed at both 3 and 7 days after operation.
Cytostatic agents
The cytostatic regimen consisted of a combination of 5-
fluorouracil (Roche Laboratories), bleomycin (Lundbeck)
and cisplatin (cis-dichlorodiammineplatinum (II), Bristol-
Meyers). The compounds were dissolved in 10 ml saline and
administered daily, by intraperitoneal injection for 5 con-
secutive days. In the cyto 1 group the dosages were 10, 2 and
0.35 mg kg-'d-' for 5-fluorouracil, bleomycin and cisplatin,
respectively. Dosages in the cyto 2 group were twice as high.
Animals in the control group received saline only.
Operative procedure
The rats were anesthesised by an intraperitoneal injection of
sodiumpentobarbital. One-centimeter segments of both ileum
and colon were resected at 15 cm proximal to the ileocecal
valve and 3 cm proximal to the rectal peritoneal reflection,
respectively; these were used as control segments. Subse-
quently, continuity was restored by the construction of an
inverted one-layer end-to-end anastomosis with eight inter-
rupted monofilament 8 x 0 sutures (EthilonO). The 4 cm mid-
line abdominal incision was closed with a 3 x 0 running silk
suture for the muscle layer and staples for the skin.
After 3 or 7 days, the rats were killed by an intraperitoneal
overdose or sodiumpentobarbital. The anastomotic segments
were isolated from the surrounding tissue and resected.
Analyticalprocedures
Bursting pressure measurements on each anastomotic seg-
ment were performed as described previously (de Roy van
Zuidewijn et al., 1986). Briefly, the isolated segment was
connected to an infusion pump on one side and a manometer
on the other side. Intraluminal pressure was increased by
pumping a 0.9% NaCl solution at a rate of 2 ml min-' into
the segment. The pressure was recorded graphically and a
sudden loss of pressure was taken to indicate leakage.
Thereafter, a 1 cm segment containing the anastomosis in the
middle was collected for biochemical analysis. The samples
were pulverised in liquid nitrogen, lyophilised, weighed and
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kept at - 30°C. In each rat, both the control segments
removed at operation and the samples containing the anas-
tomosis, were analsyed for hydroxyproline as described else-
where (Hesp et al., 1984), essentially according to Prockop
and Udenfriend (1960). This assay involves the oxidation of
free hydroxyproline to pyrrole and subsequent formation of a
chromophore with p-dimethylaminobenzaldehyde. Between 1
and 3 mg lyophilised tissue was hydrolysed overnight at 120°C
in 6N HCI. The hydrolysate was filtered through cotton gauze
and the pH was raised to approximately 8.5. Samples were
then oxidised with chloramine T and washed with toluene.
After heating the aqueous layer at 100C, pyrrole was ex-
tracted into toluene and the absorbance at 560 nm was
measured after addition of Ehrlich's solution. Statistical
methods employed are mentioned with the results.
Results
Body weight
All rats lost weight after operation (Figure 1). Comparison
(Kruskal-Wallis) of three parameters for weight loss, i.e. the
percentual maximum weight loss, the day of maximum
weight loss and the difference between weight at operation
and weight at sacrifiction, yielded significant differences
between the three groups (Table I). If the groups were com-
pared two-by-two (Wilcoxon), no differences were found
between the control and the cyto 1 groups, while each time
significant differences were present between the cyto 2 group
and the other two groups. For instance, the maximum weight
loss in the cyto 2 group was greater (P = 0.001) and reached
later (P = 0.0133) than in the control group. Thus, the high
dose of cytostatics induced more and longer-lasting loss of
weight.
Bursting pressure
The outcome of bursting pressure measurements showed a
high degree of variation within each group. Average bursting
pressures in the 3 days old anastomoses were low (Table II)
and rupture occurred, with one exception, within the anas-
tomotic line (Figure 2). Although average values in both
cytostatics groups were lower than in the control group, this
effect remained non-significant. Seven days after operation,
anastomotic strength had increased considerably. At this
time-point, comparison of the three groups yielded significant
differences, both in ileum and in colon. Again, the cyto 2
group was responsible for this effect. While control and
cyto 1 groups yielded similar results, bursting pressures in the
cyto 2 group were significantly lower than those found in the
control (P = 0.0022 in ileum, P< I0- in colon) or the cyto 1
group (P = 0.0043 in ileum, P<10- in colon). In fact, a
high dose of cytostatics seemed to prevent any gain of
strength between 3 and 7 days after operation.
In addition, comparison of the bursting site in the three
groups (cf. Figure 2) yielded significant (chi square test)
differences: P = 0.013 for ileal and P< I0- for colonic anas-
tomoses. While in the control group 7 days old anastomotic
segments always, with two exceptions in the ileum, ruptured
outside the anastomotic line, the opposite was true in the
cyto 2 group, where rupture invariably occurred within the
anastomosis.
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Figure 1 Postoperative loss of body weight. Points represent
average values from nine animals.
Table II Bursting pressures of anastomotic segments
Ileum Colon
3 days 7 days 3 days 7 days
Control 43 ± 42 (9) 156 ± 74 (8) 64 ± 36 (9) 156 ± 28 (9)
Cyto 1 25 22 (10) 114 55 (9) 49 28 (10) 152 23 (9)
Cyto 2 32 20 (10) 24 21 (9) 66 32 (8) 52 35 (9)
P ns 0.0032 ns 0.0002
Average bursting pressures, expressed in mmHg ± s.d., with the
number of animals between brackets. Differences between the three
groups tested for significance using the Kruskal-Wallis test.
Hydroxyproline concentration
Measurement of the hydroxyproline concentration allows a
direct comparison between control and anastomotic segments
within one animal. Three days after operation the hydroxy-
proline concentration within the anastomosis was signifi-
cantly below that in the control segment, both in ileum and
in colon (Figure 3). No differences were observed between
groups. However, at 7 days, when in the control group
concentrations had risen above those found in uninjured
intestine, anastomotic hydroxyproline concentrations in both
cytostatics groups still remained significantly below those in
the control segments.
Statistical comparison of the data from the three groups
together confirmed the presence of very significant differences
indeed. Comparison of the groups two-by-two (Wilcoxon)
indicated that the results for both cytostatics groups were
similar but that significant differences existed between the
control group and both the cytol group (P= 0.0001 in ileum
and P = 0.0041 in colon) and the cyto 2 group (P< I0- in
both intestinal segments). Thus, restoration of preoperative
hydroxyproline concentrations around intestinal anastomoses
was significantly delayed by the intraperitoneal administra-
tion of cytostatics.
Table I Postoperative changes in body weight
Control group Cyto I group Cyto 2 group
(n= 10) (n=9) (n=9) P
Weight at operation 203 ± 12 196 ± 11 199 ± 9 ns
Weight at sacrifiction
minus weight at operation - 11 ± 10 - 10 ± 6 -34 ± 14 0.0009
Maximal weight loss 11 ± 4 12 ± 1 20 ± 6 0.0005
Day ofmaximal weight loss 3.4 ± 1.6 3.6 ± 1.1 5.1 ± 0.9 0.0102
Average values (weight data in g) ± s.d. with the number ofanimals between brackets.
Significance based on Kruskal-Wallis test.INTRAPERITONEAL CYTOSTATICS AND INTESTINAL HEALING 939
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Figure 2 Bursting pressure and bursting site in anastomotic
segments. Each point represents a measurement in a single rat.
C = Control Group. Open circles: bursting site within anas-
tomotic line; filled circles: bursting site outside anastomotic line.
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Hydroxyproline concentrations are affected not only by
changes in segmental weight. In order to exclude the pos-
sibility that differences between groups, described above,
were caused by different changes in biopsy weight rather than
by a different hydroxyproline metabolism, it should be dem-
onstrated that changes in biopsy weight in the various groups
were similar. This is shown in Table III, which gives the
ratios between anastomotic weight and weight of the control
segments removed at operation. Variation within one group
was rather high, probably because of the practical difficulties
concomitant to the reproducible resection of 1 cm segments
from a very contractile intestinal wall. Still, the increase in
weight appeared to be the same in all groups, indicating that
the differences observed in the ratio between anastomotic and
control hydroxyproline concentrations (Figure 3) may indeed
be attributed to changes in the actual amount of hydroxy-
proline.
Hydroxyproline content
The hydroxyproline content, expressed as fig cm', is a meas-
ure for the actual amount of hydroxyproline present per
biopsy. At 3 days after operation, average values for the
anastomotic hydroxyproline content in the control group
were 224 ± 66 [n = 9] ytg cm ' in ileum and 312 ± 35 [n = 9]-
pgcm-' in colon. Similar values were found in both cyto-
statics groups. The data for 7 days old anastomoses, and
their corresponding control segments, are given in Table IV.
Unexpectedly, significant differences were found between
control segments in the three groups. In ileum, this was
mainly due to a significant (Wilcoxon, P = 0.0057) difference
between the control and the cyto 1 group, while in colon the
most pronounced difference (P =0.0076) existed between
control and cyto 2 groups. In all cases, anastomotic segments
contained more hydroxyproline than control segments. It
should be emphasised that this increase is the result not only
of collagen synthesis but is also caused by inversion of the
intestinal wall, necessary for anastomotic construction. A
1 cm anastomotic segment contains, immediately after anas-
Table III Dry weight of intestinal segments
Control Anastomotic Ratio
segment segment anast/control
Ileum
Control 15.2 3.0 (10) 51.3 11.6 (10) 3.53 1.28 (10)
Cyto 1 15.5 3.9 (9) 53.0 10.2 (9) 3.54 0.80 (9)
Cyto 2 13.1 2.1 (9) 44.2 13.6 (9) 3.41 1.10 (9)
Colon
Control 12.2 3.2 (10) 33.2 9.4 (10) 2.86 1.08 (10)
Cytol 11.7±3.4 (9) 34.3± 5.3 (9) 3.13±0.93 (9)
Cyto 2 12.7 ± 2.2 (9) 34.6 ± 6.9 (9) 2.76 ± 0.57 (9)
Data represent average weight (g ± s.d.) of 7 days old anastomotic
segments and corresponding control segments removed at operation.
No differences between the three groups were found (Kruskal-Wallis
test).
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Figure 3 Postoperative changes in hydroxyproline concentra-
tions. Values in anastomotic segments were compared to those
obtained in control segments removed at operation and resulting
mean ratios ( ± s.d.) are given. = Control Group; Cyto
Group; 1 Cyto 2 Group. Within each group, changes were
tested for significance using a signed rank test:
** = 0.001<P < 0.01. Results from the three groups were com-
pared using the Kruskal-Wallis test: *** = P < 0.001.
Table IV Hydroxyproline content of biopsy segments
Control Anastomotic Ratio
segment segment anast/control
Ileum
Control 86 ± 18 (10) 435 117 (10) 5.20 1.45 (10)
Cyto 1 138 ± 49 (9) 343 + 77 (9) 2.67 ± 0.75 (9)
Cyto 2 103 ± 11 (9) 280 ± 57 (9) 2.77 + 0.62 (9)
P 0.0104 0.0027 0.0004
Colon
Control 133 33 (10) 417 143 (10) 3.27 1.19 (10)
Cyto 1 148 + 40 (9) 390 + 91 (9) 2.76 + 0.88 (9)
Cyto 2 172 24 (9) 370 51 (9) 2.18 0.39 (9)
P 0.0371 ns 0.0380
Data represent average values (,ug hydroxyproline/cm
intestine ± s.d.) in 7 days old anastomoses and corresponding control
segments removed atoperation. Differences between three groups were
tested for significance using the Kruskal-Wallis test.
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tomotic construction, 1.5-2 times more hydroxpyroline than
the corresponding resected control segment (Mastboom &
Hendriks, unpublished results).
Ileal anastomotic hydroxyproline content in the three
groups varied significantly; two-by-two comparison (Wil-
coxon) yielded a significant (P = 0.0015) difference only
between control and cyto 2 groups. The same was true for
the ratio between anastomotic and control segments. In this
case, comparison of the two groups yielded significant
differences between the control group and both cyto 1
(P = 0.0003) and cyto 2 groups (P = 0.0002). While the
average hydroxyproline content in colonic anastomoses of
the cytostatics groups was lower than in the control group,
this effect remained non-significant. However, if the ratios
between anastomotic and control segments were compared, a
significant difference was found between the three groups.
This was caused mainly by the fact that this ratio was
significantly lower (P = 0.0101) in the cyto 2 group than in
the control group.
Discussion
Antineoplastic agents are widely employed in the treatment
of gastrointestinal malignancies. Several treatment modalities
have been studied consisting of cytostatics alone (Loehrer et
al., 1988) or of cytostatics in combination with other agents
(Wadler et al., 1989) or with radiotherapy (Boulis Wassif,
1982). Although the use of adjuvants of treatments found
effective for advanced disease has been disappointing, recent
results appear to confirm the beneficial effects of cytostatics if
administered in the immediate postoperative period (Mayer,
1990).
Since high, therapeutic, systemic drug concentrations easily
yield toxic side effects, local or regional chemotherapy may
provide a pharmacokinetic advantage through high local
concentrations of drug with a substantially lower systemic
exposure to the drug. Toxicity studies on intraperitoneal
administration of various antineoplastic agents showed that
intraperitoneal doses of 5-fluorouracil can be 1.5 times as
high as the intravenous doses (Gyves, 1985). The intra-
peritoneal dosage of cisplatin may be incrased eight-fold
before the intraperitoneally induced plasma concentration
reaches the intravenously induced plasma concentration
(Casper et al., 1983, Sugarbaker et al., 1985). The systemic
availability of intraperitoneal bleomycin was calculated to be
44% (Alberts et al., 1980). This reduced systemic availability
after intraperitoneal administration suggests that its dose can
be increased safely by a factor of two over the standard
intravenous dose.
The aim of this study was two-fold: to compare the effects
of intraperitoneal and intravenous administration and to
investigate the effects of the highest intraperitoneal dose
tolerated. Therefore we used a dose (cyto 1 group) equal to
that employed previously in experiments with intravenous
administration (de Roy van Zuidewijn et al., 1986 and 1988).
The second dose (cyto 2 group) was the highest one tolerated
by the animals. In pilot studies we found that still higher
doses yielded an unacceptably high post-operative mortality.
In order to ensure that the drug is distributed evenly
through the entire peritoneal space, the use of large volumes
of solution has been recommended (Dedrick et al., 1978) and
uniform distribution was shown when the fluid volume
caused abdominal distention (Rosenshein et al., 1978). In our
experiment this proved to be the case if cytostatics were
administered in 10 ml of saline. Normal healing of intestinal
anastomoses, represented by the control group, has been well
characterised. During the early postoperative days anas-
tomotic strength is low and anastomotic hydroxyproline con-
centrations are decreased with respect to the preoperative
values. Thereafter, strength increases and at day 7 the anas-
tomotic line has almost invariably grown stronger than the
adjacent segments. At the same time, hydroxpyroline concen-
trations rise and the anastomotic hydroxyproline content
increases, indicating considerable synthesis of collagen.
Very little is known about the effects of intraperitoneal
chemotherapy on intestinal wound healing. Wiznitzer et al.
(1973) investigated the effects of single and multiple in-
traperitoneal injections of mitomycin, in doses usually
administered intravenously, on anastomoses in the small
intestine. After 8 days neither breaking strength nor hydroxy-
proline concentrations were different from the control group.
However, no data were provided on the breaking site and
hydroxyproline concentrations were only expressed on the
basis of wet weight, which hampers interpretation of these
results (Hendriks & Mastboom, 1990). More recently, Hillan
et al. (1988) reported that intraperitoneal 5-fluorouracil,
administered postoperatively, did not adversely affect the
breaking strength of colonic anastomoses. Again, no data
were provided on the breaking site and the fact that measure-
ments were performed after 14 days only may very well
preclude the observation of early effects.
In the present experiment we demonstrated that intra-
peritoneal cytostatics, administered in the peri-operative per-
iod, are detrimental to the healing of intestinal anastomoses.
This is unequivocally the case in the high dosage - cyto 2 -
group. The cytostatics load employed here also affects the
general condition of the animals, resulting in a higher and
more sustained weight loss than normally encountered after
resection and anastomosis. Still a transient loss of body
weight of approximately 20% would in itself not be enough
to impair healing to a significant degree (Irvin & Hunt,
1974). In this group the collagen synthesis between 3 and 7
days after operation is strongly inhibited: this is apparent
both from the delay in restoration of preoperative hydroxy-
proline concentrations (Figure 3) and from the reduced ratio
between anastomotic and control-segment hydroxyproline
content (Table IV). The result is a dramatic loss of anas-
tomotic bursting pressure. Clearly, such a cytostatic regimen
represents a great risk for anastomotic failure.
The effects of the lower dose of cytostatics, equivalent to
that given intravenously in a previous experiment (de Roy
van Zuidewijn et al., 1986), are less dramatic. Although the
hydroxyproline parameters measured are affected to a similar
extent in both cyto 1 and cyto 2 groups, certainly in the small
bowel, this is not reflected in a significant loss of strength.
The average bursting pressures in the anastomotic segments
from the control and cyto 1 groups do not differ significantly.
Still, some effect is present since in the cyto 1 group the
bursting site is located more frequently within the suture line.
This apparent discrepancy between biochemical and
mechanical parameters again support the thesis that the
amount of collagen present is not the only parameter which
decides on anastomotic strength (Hendriks & Mastboom,
1990). It seems quite conceivable that both cytostatic regimen
inhibit collagen synthesis, but that e.g. collagen cross-linking
is still sufficient to allow a gain in strength in the cyto 1
group while this process is impaired in the cyto 2 group, thus
preventing the anastomosis to grow any stronger in the first
week after operation.
Finally, the question arises whether intraperitoneal
administration of cytostatics is less harmful to anastomotic
repair than intravenous administration. If we compare the
results of the present cyto 1 group to those obtained before
with the same drugs after systemic administration (de Roy
van Zuidewijn et al., 1986), indications can be found that this
is indeed the case. While we observed no effects whatsoever 3
days after operation during intraperitoneal cytostatics, in-
travenous administration resulted in a severe depression of
bursting pressure in ileal anastomoses; both 3 and 7 days
after operation. As a consequence our conclusion is that,
while local intraperitoneal application of cytostatics is prob-
ably less deleterious to anastomotic healing than systemic
administration of a similar dose, significant increases in the
dose given intraperitoneally are contraindicated because of
their negative effects on intestinal repair. This outcome limits
the usefulness of intraperitoneal chemotherapy as an adjunct
to surgery.INTRAPERITONEAL CYTOSTATICS AND INTESTINAL HEALING 941
The authors are grateful to the staff of the Central Animal Labora-
tory of the Faculty of Medicine (head; Prof Dr W.J.I. van der
Gulden) for administering the antineoplastic agents, to B.M. de Man
for expert technical assistance and to Th.M. de Boo for performing
the statistical analyses.
References
ALBERTS, D.S., CHEN, H.S.G., CHANG, S.Y. & PENG, Y.M. (1980).
The disposition of intraperitoneal bleomycin, melphalan and
vinblastine in cancer patients. Recent Results Cancer Res., 74,
293.
BOULIS WASSIF, S. (1982). The role of pre-operative adjuvant ther-
apy in the management of borderline operability rectal cancer.
Clin. Radiol., 33, 353.
CASPER, E.S., KELSEN, D.P., ALCOCK, N.W. & LEWIS, J.L. (1983). IP
cisplatin in patients with malignant ascites: pharmacokinetic eval-
uation and comparison with the IV route. Cancer Treat. Rep., 67,
235.
CUNLIFFE, W.J. & SUGARBAKER, P.H. (1989). Gastrointestinal mal-
ignancy: rationale for adjuvant therapy using early postoperative
intraperitoneal chemotherapy. Br. J. Surg., 76, 1082.
DEDRICK, R.L., MEYERS, C.E., BUNGAY, P.M. & DEVITA, V.T.
(1978). Pharmacokinetic rationale for peritoneal drug administra-
tion in the treatment of ovarian cancer. Cancer Treat. Rep., 62, 1.
FALCONE, R.E. & NAPPI, J.F. (1984). Chemotherapy and wound
healing. Surg. Clin. N. Am., 64, 779.
GYVES, J. (1985). Pharmacology of intraperitoneal infusion 5-fluor-
ouracil and mitomycin-C. Sem. in Oncol., 12 (suppl), 29.
HENDRIKS, TH. & MASTBOOM, W.J.B. (1990). Healing of experi-
mental intestinal anastomoses: Parameters of repair. Dis. Colon
Rectum, 33, 891-901.
HESP, W.L.E.M., HENDRIKS, T., LUBBERS, E.J.C. & DE BOER, H.H.M.
(1984). Wound healing in the intestinal wall. A comparison
between experimental ileal and colonic anastomoses. Dis. Colon
Rectum, 27, 99.
HILLAN, K., NORDLINGER, B., BALLET, F., PUTS, J.P. & INFANTE,
R. (1988). The healing of colonic anastomoses after early intra-
peritoneal chemotherapy: an experimental study in rats. J. Surg.
Res., 44, 166.
IRVIN, T.T. & HUNT, T.K. (1974). Effect of malnutrition on colonic
healing. Ann. Surg., 180, 765.
LOEHRER, P.J., TURNER, S., KUBILIS, P. & 6 others (1988). A pro-
spective randomized trial of fluorouracil versus fluorouracil plus
cisplatin in the treatment of metastatic colorectal cancer: a
Hoosier Oncology Group trial. J. Clin. Oncol., 6, 642.
MAYER, R.J. (1990). Does adjuvant therapy work in colon cancer?
New Engi. J. Med., 322, 399.
PROCKOP, D.J. & UDENFRIEND, S.A. (1960). A specific method for
the analysis of hydroxyproline in tissues and urine. Anal. Bio-
chem., 1, 228.
ROSENSHEIN, N., BLAKE, D., MCINTYRE, P.A & 4 others (1978). The
effect of volume on the distribution of substances instilled into
the peritoneal cavity. Gynecol. Oncol., 6, 106.
DE ROY VAN ZUIDEWIJN, D.B.W., WOBBES, TH., HENDRIKS, TH.,
KLOMPMAKERS, A.A. & DE BOER, H.H.M. (1986). The effects of
antineoplastic agents on the healing of small intestinal anas-
tomoses in the rat. Cancer, 58, 62.
DE ROY VAN ZUIDEWIJN, D.B.W., WOBBES, TH., HENDRIKS, TH.,
KLOMPMAKERS, A.A. & DE BOER, H.H.M. (1988). The effect of
cisdichlorodiammineplatinum(II) on the healing of experimental
intestinal anastomoses in the rat. Surg. Res. Comm., 2, 297.
SUGARBAKER, P.H., GIANOLA, F.J., SPEYER, J.C., WESLEY, R.,
BAROFSKY, I. & MEYERS, C.E. (1985). Prospective, randomized
trial of intravenous versus intraperitoneal 5-fluorouracil in pa-
tients with advanced primary colon or rectal cancer. Surgery, 98,
414.
WADLER, S., SCHWARTZ, E.L., GOLDMAN, M. & 4 others (1989).
Fluorouracil and recombinant afla-2a-interferon: an active regi-
men against advanced colorectal carcinoma. J. Clin. Oncol., 7,
1769.
WIZNITZER, TH., ORDA, R., BAWNIK, J.B., RIPPIN, A., GRIFFEL, B.
& HERZBERG, M. (1973). Mitomycin and the healing of intestinal
anastomosis. Arch. Surg., 106, 314.